Evidence map›Paper›PMID 32144406›Full record

ReviewNature reviews. Molecular cell biology2020

Cellular adaptation to hypoxia through hypoxia inducible factors and beyond.

Pearl Lee, Navdeep S Chandel, M Celeste Simon

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Molecular cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06309459 (Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma), which is not on this map. Cited by 726 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
726citing papers in PubMed, 2 pooled it
49.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06309459 completednot on this map

Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma: Relationship With Prognostic Factors and Response to Neoadjuvant Chemotherapy

TypeobservationalSponsorKahramanmaras Sutcu Imam UniversityRan2018 to 2023Enrolled40ConditionsTriple Negative Breast Cancer, Carbonic Anhydrase IXArmsCarbonic anhydrase staining levels
3 · Its place in the literature

Who cites it

726 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,175 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. A conserved eIF1ACell reports. Medicine · 2026
    Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Variants ofLife science alliance · 2026
    Article
  20. Article

666 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Pearl LeeAbramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. pearllee@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-1274-2891
Navdeep S ChandelDepartment of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. nav@northwestern.edu.ORCID http://orcid.org/0000-0001-7208-3886
M Celeste SimonAbramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. celeste2@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0001-9106-447X
Cancer Research Institute · USNorthwestern University · US

Funding

TRANSLATIONAL CONTROL IN ADAPTATION TO HYPOXIAP01CA104838 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SIMON, M. CELESTE · 2004 to 2018
$17.6M
Metabolic Tumor Suppressors in Renal Cancer: Unprecedented Roles in Disease ProgressionR35CA220483 · NCI · UNIVERSITY OF PENNSYLVANIA · PI M. CELESTE SIMON · 2017 to 2026
$9.4M
Mitochondrial metabolism and ROS regulate cancerR35CA197532 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHANDEL, NAVDEEP S · 2016 to 2022
$6.3M
Training in Muscle Biology and Muscle DiseaseT32AR053461 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI OSTAP, E. MICHAEL · 2006 to 2025
$4.9M
HIFs and VEGF in sarcoma progression, metastasis, and radiation responseR01CA158301 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SIMON, M. CELESTE, YOON, SAM SUNGHYUN · 2011 to 2021
$4.1M
Metabolic alterations in soft tissue sarcoma initiation and progressionF32CA217185 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LEE, PEARL · 2017 to 2018
$116k
NCI NIH HHS F32 CA217185NCI NIH HHS P01 CA104838NCI NIH HHS R01 CA158301NCI NIH HHS R35 CA197532NCI NIH HHS R35 CA220483NIAMS NIH HHS T32 AR053461
6 · The paper itself

Abstract

Molecular oxygen (O

Indexed as

Adenosine TriphosphateCell HypoxiaEnergy MetabolismHumansMitochondriaOxidative StressOxygenReactive Oxygen SpeciesSignal TransductionAdenosine TriphosphateOxygenReactive Oxygen Species

Identifiers

PMID32144406
PMCPMC7222024
OpenAlexW3009721059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.